IT Earnings Season: A Muted Start But Hints of a 2026 AI Boom - Professional coverage
AIBusinessSoftware

IT Earnings Season: A Muted Start But Hints of a 2026 AI Boom

According to Bloomberg Business, the upcoming earnings season for major IT firms is expected to be muted but could offer…

MIT's 2026 Tech Forecast: From AI Companions to Greener Grids - Professional coverage
AIInnovationSoftware

MIT’s 2026 Tech Forecast: From AI Companions to Greener Grids

According to Forbes, MIT Technology Review has outlined the major tech trends to watch in 2026, focusing on energy, AI,…

AI Isn't a Mind. It's a Market. And That's a Bigger Deal. - Professional coverage
AIBusinessInnovation

AI Isn’t a Mind. It’s a Market. And That’s a Bigger Deal.

According to Bloomberg Business, a group of social and cognitive scientists is pushing a provocative new metaphor for understanding artificial…

ResearchScience

Oral Microbiome Imbalance Linked to Multiple Sclerosis in Groundbreaking Study

A comprehensive study has identified distinct oral microbiome and metabolome profiles in relapsing-remitting multiple sclerosis patients. Researchers found decreased beneficial bacteria and significantly lower hypotaurine levels, potentially opening new avenues for diagnosis and treatment. The findings suggest the oral environment may play a crucial role in MS pathobiology.

Significant Oral Microbiome Differences Identified

People with relapsing-remitting multiple sclerosis (RRMS) exhibit distinct oral microbiome compositions compared to healthy individuals, according to a recent study published in npj Biofilms and Microbiomes. The research, which analyzed 50 RRMS patients and 50 healthy controls through shotgun metagenomic sequencing and untargeted metabolomics, revealed numerous previously unidentified salivary alterations that sources indicate could provide new diagnostic and therapeutic targets.

ResearchScience

Breakthrough Mouse Model Uncovers Novel Treatment Pathways for Rare Genetic Inflammatory Disorder

Scientists have created a groundbreaking mouse model that replicates NLRC4-associated autoinflammatory disease with infantile enterocolitis. The research reveals unexpected therapeutic potential in glucose supplementation alongside conventional cytokine blockade, offering new hope for treating this rare genetic condition.

Novel Animal Model Replicates Human Autoimmune Disorder

Researchers have developed a breakthrough animal model that accurately mimics NLRC4-associated autoinflammatory disease with infantile enterocolitis (AIFEC), according to a recent study published in Cellular & Molecular Immunology. The model reportedly provides crucial insights into disease mechanisms and has uncovered unexpected therapeutic strategies, including glucose supplementation alongside conventional anti-inflammatory approaches.

SoftwareStartups

Startup Post-Mortem Reveals Widespread Technical Debt as Primary Failure Catalyst

A comprehensive review of 47 startup failures reveals a consistent technical pattern that doomed their growth prospects. The analysis suggests most companies followed an identical timeline toward technical insolvency despite varying business models and markets.

Pattern Emerges in Startup Autopsies

Technical debt accumulation represents the most common fatal flaw among failed technology startups, according to reports analyzing nearly 50 collapsed ventures. Sources indicate that despite varying business models and target markets, the majority of these companies followed an identical trajectory toward technical insolvency that ultimately prevented scaling and led to their demise.